Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CBAY | RDY | SUPN | ||
| Company | Cymabay Therapeutics | Dr. Reddy's Laboratories Ltd ADR | Supernus Pharm | ||
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | ||
| Open | 32.49 | 13.40 | 51.62 | ||
| High | 32.50 | 13.60 | 51.71 | ||
| Low | 32.48 | 13.31 | 50.00 | ||
| Latest | 32.48 | 13.31 | 50.68 | ||
| Change | +0.01 | +0.05 | -0.82 | ||
| % Change | +0.03% | +0.38% | -1.59% | ||
| Volume | 8,356,200 | 1,622,400 | 445,300 | ||
| 20-Day Average Volume | 3,390,805 | 2,444,320 | 604,420 | ||
| Previous Close | 32.47 | 13.26 | 51.50 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 32.35 | 13.62 | 50.20 | ||
| 20-Day Raw Stochastic | 94.12% | 32.00% | 65.70% | ||
| 20-Day Relative Strength | 78.00 | 42.96 | 49.10 | ||
| Weighted Alpha | +247.60 | -3.58 | +52.12 | ||
| Today's Opinion | 100% Buy | 88% Sell | 56% Buy | ||
| Previous Opinion | 100% Buy | 88% Sell | 72% Buy | ||
| Last Month's Opinion | 100% Buy | 40% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.03% since 03/14/24 | -0.08% since 04/02/26 | +0.40% since 04/02/26 | ||
| Low | 32.44 on 03/15/24 | 12.83 on 04/07/26 | 49.56 on 04/07/26 | ||
| High | 32.50 on 03/21/24 | 13.60 on 04/10/26 | 52.37 on 04/08/26 | ||
| 1-Month | |||||
| %Chg | +0.90% since 02/21/24 | -8.27% since 03/10/26 | -5.57% since 03/10/26 | ||
| Low | 32.15 on 02/22/24 | 12.83 on 04/07/26 | 46.83 on 03/20/26 | ||
| High | 32.50 on 03/21/24 | 14.55 on 03/11/26 | 53.41 on 03/11/26 | ||
| 3-Month | |||||
| %Chg | +46.17% since 12/21/23 | -0.67% since 01/09/26 | -0.84% since 01/09/26 | ||
| Low | 22.11 on 01/26/24 | 12.81 on 01/20/26 | 46.83 on 03/20/26 | ||
| High | 32.50 on 03/21/24 | 14.80 on 02/25/26 | 59.68 on 02/25/26 | ||
| 6-Month | |||||
| %Chg | +122.47% since 09/21/23 | -7.18% since 10/10/25 | +3.43% since 10/10/25 | ||
| Low | 12.32 on 10/13/23 | 12.81 on 01/20/26 | 43.11 on 11/05/25 | ||
| High | 32.50 on 03/21/24 | 14.95 on 10/22/25 | 59.68 on 02/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,726,235 | 11,109,111 | 2,918,256 | ||
| Shares Outstanding, K | 114,724 | 834,644 | 57,582 | ||
| Annual Sales | 31,070,000 | 3,811,000,000 | 718,950,000 | ||
| Annual Net Income | -105,370,000 | 663,000,000 | -38,550,000 | ||
| Last Quarter Sales | 60,000 | 977,400,000 | 211,570,000 | ||
| Last Quarter Net Income | -41,900,000 | 135,500,000 | -4,110,000 | ||
| 60-Month Beta | 0.32 | 0.35 | 0.73 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.35 on 02/28/24 | 0.16 on 01/21/26 | 0.92 on 02/24/26 | ||
| Latest Earnings Date | 05/20/24 | 05/08/26 | 05/05/26 | ||
| Most Recent Dividend | N/A | 0.071 on 07/25/25 | N/A | ||
| Next Ex-Dividends Date | N/A | 07/25/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.22 | 22.69 | ||